Northwest Sports & Spine

07/13/2022

Applying Lessons from Ultramarathons and Embracing Adaptability in Rehabilitation with Lisa Bliss MD

Applying Lessons from Ultramarathons and Embracing Adaptability in Rehabilitation with Lisa Bliss MD July 11, 2022/in Powering Health & Wellness /by RPM Rehab Ultramarathon athlete, Physiatrist and rehabilitation medicine specialist Lisa Bliss MD explains how physicians adapt individual care plans t...

02/27/2019

The Generic Drug User Fee Amendments (GDUFA), passed by Congress in 2012, were intended to speed U.S. Food and Drug Administration approval of new generic drugs, which create competition for brand drugs and reduce drug prices for consumers.

12/20/2018

The new label warning states that fluoroquinolones should not be used in patients "with a history of blockages or aneurysms (abnormal bulges) of the aorta or other blood vessels, high blood pressure, certain genetic disorders that involve blood vessel changes, and the elderly." These warnings must be added to the prescribing information and the patient medication guide, the FDA said.

Moreover, the FDA said that healthcare professionals should avoid prescribing these antibiotics to patients with aortic aneurysm or those at risk for aortic aneurysm, unless no other treatment options are available. These patient groups at increased risk include "patients with peripheral atherosclerotic vascular diseases, hypertension, certain genetic conditions such as Marfan syndrome and Ehlers-Danlos syndrome, and elderly patients," the agency said.

Adds to already long list of issues with popular antibiotic class

12/13/2018

Choosing — or starting treatment with — manual therapy over opioid medications for the management of spine or shoulder may result in lower associated downstream costs.

12/12/2018

Assistance Dogs International, Inc. (ADI) is a worldwide coalition of non-profit programs that train and place Assistance Dogs. Founded in 1986 from a group of seven small programs, ADI has become the leading authority in the Assistance Dog industry.

11/06/2015

The investigation starts. I suspect it's going to move as quickly as the Lance Armstrong investigation, but at least the Big Phrama MO is being questioned rather than naively accepted. Finally. I guess we can thank Martin Shkreli (http://www.thedailybeast.com/…/martin-shkreli-is-big-pharma…) for bringing himself into the spotlight and making this issues a bit more public.

Orthopedics Members of Congress Put Costly Drugs in Their Crosshairs Additional Orthopedics Coverage 11/5/2015 - Shannon Firth WASHINGTON -- Prescription drug prices are getting more attention on Capitol Hill, with two senators from opposite sides of the aisle announcing plans to investigate while…

10/26/2015

An excellent video for all us outdoor enthusiasts, particularly geared toward cyclists.

(Visit: http://www.uctv.tv) Professor of Clinical Dermatology at UCSF, Timothy Berger, MD examines the many challenges a cyclist's skin can face while out ri...

10/21/2015

New Breast Cancer Screening Guidelines from the ACS:

Recommendations The ACS recommends that women with an average risk of breast cancer should undergo regular screening mammography starting at age 45 years (strong recommendation). Women aged 45 to 54 years should be screened annually (qualified recommendation). Women 55 years and older should transition to biennial screening or have the opportunity to continue screening annually (qualified recommendation). Women should have the opportunity to begin annual screening between the ages of 40 and 44 years (qualified recommendation). Women should continue screening mammography as long as their overall health is good and they have a life expectancy of 10 years or longer (qualified recommendation). The ACS does not recommend clinical breast examination for breast cancer screening among average-risk women at any age (qualified recommendation).

03/06/2015

I am happy to announce that I have again been named among the area's Best Doctors, as voted by my peers. I think this is 11 years in a row. (Page 114)

http://issuu.com/ksomday/docs/scl112

Best Doctors Issue

03/06/2015

Remember, supplements purchased in stores or online are not regulated by the FDA. You never know if the product has in it what it claims to have in it. Maybe less, maybe more, maybe none.
_________________________________

FDA to require warning on labels of testosterone products.

USA Today (3/4, Szabo) reports on Tuesday the US Food and Drug Administration announced it will require manufacturers of prescription testosterone therapy “to include a warning about health risks on product labels,” and the agency advised men using such products to “contact a doctor if they develop symptoms of heart attack or stroke.”

The New York Times (3/4, A16, Tavernise, Subscription Publication) reports that two studies suggesting an association between testosterone use and heart problems prompted the FDA to reassess the safety of the products last year, and a panel of independent experts “voted overwhelmingly in September that the labels should be changed to reflect the heart risks.” In a statement, the FDA said “We are requiring that the manufacturers of all approved prescription testosterone products change their labeling to clarify the approved uses of these medications.” According to an agency spokeswoman, companies were expected to respond by Tuesday.

According to the AP (3/4, Perrone), the FDA will also require manufacturers to “conduct a long-term study to further examine the issue.”

The Wall Street Journal (3/4, Burton, Subscription Publication) reports that a study published in JAMA in November 2013 found a 30-percent increased risk of death, heart attack, or stroke in men using testosterone, while an NIH-funded study of 56,000 men published in the journal PLOS One found that men over 65, or men under 65 with a history of heart disease, were more likely to experience a heart attack if they used testosterone products.

The Los Angeles Times (3/4, Healy) “Science Now” blog reports that the new FDA warning will require labels “to clarify that the prescription hormone is meant for use by men whose low testosterone levels are caused by certain medical conditions,” such as “genetic disorders and conditions affecting the testicles, pituitary gland and brain.”

03/06/2015

Are you on a cholesterol-lowering drug? You should be informed that those drugs may increase risk of diabetes.
___________________________
Statin therapy appears to increase men’s risk for type 2 diabetes.

Bloomberg News (3/5, Cortez) reports, “Millions of people take pills known as statins each year to lower their cholesterol levels.” Now, “a new study shows the medicine also raises their risk of developing diabetes.”

TIME (3/5, Park) reports that the study published online March 4 in the journal Diabetologia suggests that “men prescribed statins to lower their cholesterol had a 46% greater chance of developing diabetes after six years compared to those who weren’t taking the drug.” In addition, “the statins seemed to make people more resistant to the effects of insulin—which breaks down sugar—and to secrete less insulin.” Time adds, “For patients who may not yet be diabetic, but are vulnerable to developing the disease and also may need a statin, Dr. Neil Stone, lead author of the 2013 American College of Cardiology and American Heart Association cholesterol guidelines, says he stresses the importance of lifestyle changes in diet and exercise.”

Medscape (3/5, Davenport) reports that researchers arrived at these conclusions after investigating “the effects of statin treatment on blood glucose control and the risk for type 2 diabetes in 8749 nondiabetic men age 45 to 73 years in a 6-year follow-up of the population-based Metabolic Syndrome in Men (METSIM) trial.”

12/21/2014

Simple informative test to assess Type 2 Diabetes Risk.

Find out your risk for type 2 diabetes.